BiotechTube
Home/Xenon Pharmaceuticals/Matthew D. Ronsheim
MD

Matthew D. Ronsheim

Chief Operating Officer

Xenon Pharmaceuticals

Therapeutic Areas

NeurologyPsychiatry

Xenon Pharmaceuticals Pipeline

DrugIndicationPhase
Azetukalner (XEN1101)Focal Onset SeizuresPhase 3
XEN1701PainPhase 1
XEN1120Undisclosed (Kv7 target)Phase 1

Leadership Team at Xenon Pharmaceuticals

IM
Ian Mortimer
President and Chief Executive Officer
DC
Darren Cline
Chief Commercial Officer
AD
Andrea DiFabio
Chief Legal Officer and Corporate Secretary
JE
James Empfield
Executive Vice President, Drug Discovery
TK
Tucker Kelly
Chief Financial Officer
CK
Chris Kenney
Chief Medical Officer
SM
Shelley McCloskey
Executive Vice President, Human Resources
RS
Robin Sherrington
Executive Vice President, Strategy and Innovation
View full Xenon Pharmaceuticals profile